Gastroesophageal reflux and serum biomarkers in systemic sclerosis-associated interstitial lung disease: comment on the article by Elhai et al Reply

被引：0
|
作者：
Elhai, Muriel [1 ,2 ]
Hoffmann-Vold, Anna Maria [3 ,4 ]
Allanore, Yannick [1 ,2 ]
机构：
[1] Paris Descartes Univ, Cochin Inst, INSERM U1016, UMR8104, Paris, France
[2] Paris Descartes Univ, Cochin Hosp, Paris, France
[3] Oslo Univ Hosp, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷 / 07期
关键词：
D O I：
10.1002/art.40908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1204 / 1206
页数：3
相关论文
共 50 条
  • [1] Gastroesophageal Reflux and Serum Biomarkers in Systemic Sclerosis-Associated Interstitial Lung Disease: Comment on the Article by Elhai et al
    Moiseev, Sergey
    Sosnovskaya, Antonina
    Chotchaeva, Fatima
    Shchegoleva, Elena
    Novikov, Pavel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1203 - 1204
  • [2] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    C. Meier
    K. Freiburghaus
    C. Bovet
    J. Schniering
    Y. Allanore
    O. Distler
    C. Nakas
    B. Maurer
    Scientific Reports, 10
  • [3] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] SERUM METABOLITES AS BIOMARKERS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Distler, O.
    Nakas, C.
    Maurer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1108 - 1108
  • [5] Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Elhai, Muriel
    Hoffmann-Vold, Anna Maria
    Avouac, Jerome
    Pezet, Sonia
    Cauvet, Anne
    Leblond, Agathe
    Fretheim, Havard
    Garen, Torhild
    Kuwana, Masataka
    Molberg, Oyvind
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) : 972 - 982
  • [6] Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?
    Proudman, Susanna M.
    Corte, Tamera J.
    RESPIROLOGY, 2021, 26 (05) : 406 - 408
  • [7] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [8] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    Rheumatology International, 2011, 31 : 841 - 842
  • [9] Assessment of hand involvement in systemic sclerosis by ultrasonography: comment on the article by Elhai et al Reply
    Elhai, Muriel
    Guerini, Henri
    Bazeli, Ramin
    Avouac, Jerome
    Freire, Veronique
    Drape, Jean-Luc
    Kahan, Andre
    Allanore, Yannick
    ARTHRITIS CARE & RESEARCH, 2013, 65 (06) : 1016 - 1016
  • [10] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
    Distler, Oliver
    Gahlemann, Martina
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
12345